SmartPros Ltd. (SPRO) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TD Cowen Upgrades Spero Therapeutics (SPRO) to Buy
August 6, 2024 7:22 AM EDTTD Cowen analyst Ritu Baral upgraded Spero Therapeutics (NASDAQ: SPRO) from Hold to Buy.
The analyst comments "2Q24: We are upgrading SPRO to Buy on new clarity on catalyst timing and optimism for '720 Ph2a data in the 2nd half of... More
